Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Generation of an inducible mouse model to reversibly silence Stat3

Alorro MG, Pierce TP, Eissmann MF, Dijkstra C, Dickins RA, Ernst M, Buchert M, Masson F

(2017), Genesis, 55(4), e23023

DOI: 10.1002/dvg.23023

Self-Assembled Nanoparticles from Phenolic Derivatives for Cancer Therapy

Dai Y, Guo J, Wang TY, Ju Y, Mitchell AJ, Bonnard T, Cui J, Richardson JJ, Hagemeyer CE, Alt K, Caruso F

(2017), Adv Healthc Mater, 6(16), 1700467

DOI: 10.1002/adhm.201700467

Application of a strain rate gradient microfluidic device to von Willebrand's disease screening

Brazilek RJ, Tovar-Lopez FJ, Wong AKT, Tran H, Davis AS, McFadyen JD, Kaplan Z, Chunilal S, Jackson SP, Nandurkar H, Mitchell A, Nesbitt WS

(2017), Lab Chip, 17(15), 2595-608

DOI: 10.1039/c7lc00498b

Antibody functional assays as measures of Fc receptor-mediated immunity to HIV - New technologies and their Impact on the HIV vaccine field.

Wines BD, Billings H, Mclean MR, Kent SJ, Hogarth PM

(2017), Curr HIV Res, 15(3), 202-15

DOI: 10.2174/1570162X15666170320112247

Utility of risk-based chlamydia testing in primary care: analysis of retrospective surveillance data among women in Melbourne, Australia.

Wilkinson AL, McNamee K, El-Hayek C, Chow EP, Bradshaw CS, Roth N, Tee BK, Stoov« M, Hellard M

(2017), Sex Health, 14(3), 268-73

DOI: 10.1071/SH16202

Measuring transitions in sexual risk among Men Who Have Sex With Men: The novel use of latent class and latent transition analysis in HIV sentinel surveillance.

Wilkinson AL, El-Hayek C, Fairley CK, Roth N, Tee BK, McBryde E, Hellard M, Stoov« M

(2017), Am J Epidemiol, 185(8), 627-35

DOI: 10.1093/aje/kww239

Fc functional antibodies in humans with severe H7N9 and seasonal influenza.

Vanderven HA, Liu L, Ana-Sosa-Batiz F, Nguyen TH, Wan Y, Wines B, Hogarth PM, Tilmanis D, Reynaldi A, Parsons MS, Hurt AC, Davenport MP, Kotsimbos T, Cheng AC, Kedzierska K, Zhang X, Xu J, Kent SJ

(2017), JCI Insight, 2(13), e92750

DOI: 10.1172/jci.insight.92750

Decreased levels of platelet-derived soluble glycoprotein VI detected prior to the first diagnosis of coronary artery disease in HIV-positive individuals.

Trevillyan JM, Gardiner EE, Andrews RK, Maisa A, Hearps AC, Al-Tamimi M, Crowe SM, Hoy JF

(2017), Platelets, 28(3), 301-4

DOI: 10.1080/09537104.2016.1237627

Simultaneous ATR-FTIR based determination of malaria parasitemia, glucose and urea in whole blood dried onto a glass slide.

Roy S, Perez-Guaita D, Andrew DW, Richards JS, McNaughton D, Heraud P, Wood BR

(2017), Anal Chem, 89(10), 5238-45

DOI: 10.1021/acs.analchem.6b04578

Integrase-resistant HIV in an antiretroviral-naive patient in Australia.

Rafiei N, Woolley I, Korman TM, Chibo D, Gooey M, McMahon JH

(2017), AIDS, 31(4), 598-600

DOI: 10.1097/QAD.0000000000001377

Comparing non-occupational post-exposure prophylaxis drug regimens for HIV: insights from a linked HIV surveillance system.

Pierce AB, El-Hayek C, McCarthy D, Armishaw J, Watson K, Wilkinson A, Price B, Wright EJ, Hoy JF, Stoov« MA

(2017), Sex Health, 14(2), 179-87

DOI: 10.1071/SH16132

Feasibility of antiretroviral treatment monitoring in the era of decentralized HIV care: a systematic review.

Pham MD, Romero L, Parnell B, Anderson DA, Crowe SM, Luchters S

(2017), AIDS Res Ther, 14(1), 3

DOI: 10.1186/s12981-017-0131-5

Multimodal vibrational imaging of cells.

Perez-Guaita D, Kochan K, Martin M, Andrew DW, Heraud P, Richards JS, Wood SR

(2017), Vibr Spectrosc, 91, 46-58

DOI: 10.1016/j.vibspec.2016.07.017

Injecting drug use in low and middle income countries: opportunities to improve care and prevent harm.

O'Keefe D, Stoov« M, Doyle J, Dietze P, Hellard M

(2017), J Viral Hepat, 24(9), 714-24

DOI: 10.1111/jvh.12741

Genetics of HIV-associated sensory neuropathy and related pain in Africans.

Ngassa Mbenda HG, Wadley A, Lombard Z, Cherry C, Price P, Kamerman P

(2017), J Neurovirol, 23(4), 511-9

DOI: 10.1007/s13365-017-0532-1

No adverse safety or virological changes two years following vorinostat in HIV-infected individuals on antiretroviral therapy.

Mota TM, Rasmussen TA, Rhodes A, Tennakoon S, Dantanarayana A, Wightman F, Hagenauer M, Roney J, Spelman T, Purcell DF, McMahon J, Hoy JF, Prince HM, Elliott JH, Lewin SR

(2017), AIDS, 31(8), 1137-41

DOI: 10.1097/QAD.0000000000001442

Less frequent CD4 monitoring in virologically suppressed HIV.

McMahon J, Crowe SM

(2017), Lancet HIV, 4(6), e233-4

DOI: 10.1016/S2352-3018(17)30070-X

Post-treatment control in an adult with perinatally acquired HIV following cessation of antiretroviral therapy.

McMahon JH, Chang J, Tennakoon S, Dantanarayana A, Solomon A, Cherry C, Doherty R, Cameron P, Lewin SR

(2017), AIDS, 31(9), 1344-6

DOI: 10.1097/QAD.0000000000001472

Dimeric Fc? receptor enzyme-linked immunosorbent assay to study HIV-specific antibodies: a new look into breadth of Fc? receptor antibodies induced by the RV144 Vaccine Trial.

McLean MR, Madhavi V, Wines BD, Hogarth PM, Chung AW, Kent SJ

(2017), J Immunol, 199(2), 816-26

DOI: 10.4049/jimmunol.1602161

Differing rates of antibody acquisition to merozoite antigens in malaria: implications for immunity and surveillance.

McCallum FJ, Persson KM, Fowkes FJ, Reiling L, Mugyenyi CK, Richards JS, Simpson JA, Williams TN, Gilson PR, Hodder AN, Sanders PR, Anders RF, Narum DL, Chitnis C, Crabb BS, Marsh K, Beeson JG

(2017), J Leukoc Biol, 101(4), 913-25

DOI: 10.1189/jlb.5MA0716-294R

237 238 239 240 241